Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$232.24 - $267.23 $6,038 - $6,947
-26 Reduced 2.93%
862 $210,000
Q3 2023

Nov 08, 2023

SELL
$254.9 - $283.59 $1,529 - $1,701
-6 Reduced 0.67%
888 $229,000
Q4 2022

Feb 07, 2023

BUY
$218.29 - $256.91 $195,151 - $229,677
894 New
894 $227,000
Q4 2018

Feb 13, 2019

SELL
$204.73 - $257.93 $102,365 - $128,965
-500 Reduced 35.87%
894 $201,000
Q3 2017

Nov 13, 2017

BUY
$186.89 - $198.9 $260,524 - $277,266
1,394
1,394 $273,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Salzhauer Michael Portfolio

Follow Salzhauer Michael and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salzhauer Michael, based on Form 13F filings with the SEC.

News

Stay updated on Salzhauer Michael with notifications on news.